中国组织工程研究与临床康复
中國組織工程研究與臨床康複
중국조직공정연구여림상강복
JOURNAL OF CLINICAL REHABILITATIVE TISSUE ENGINEERING RESEARCH
2009年
53期
10569-10572
,共4页
罗显荣%曾国兵%刘树仁%任长发%杨永红%苏丽萍
囉顯榮%曾國兵%劉樹仁%任長髮%楊永紅%囌麗萍
라현영%증국병%류수인%임장발%양영홍%소려평
肝移植%急性肾功能不全%并发症%诊治
肝移植%急性腎功能不全%併髮癥%診治
간이식%급성신공능불전%병발증%진치
背景:肝移植后,由于手术创伤和免疫抑制剂的应用极易造成急性肾功能不全,其诊断和治疗,目前尚无统一诊断标准.目的:分析肝移植后肾功能不全的相关因素和诊治经验.设计、时间及地点:2004-01/2006-12在解放军第四五八医院完成.对象:肝移植37例,男35例,女2例,年龄37~67岁,平均(48.5±8.9)岁.根据原发病分为肝硬化组21例,包括乙型肝炎后肝硬化16例,丙型肝炎后肝硬化4例,酒精性肝硬化1例,均为肝硬化失代偿期;肝癌组16例.移植后均经病理检查确诊.方法:按背驮式改进方法实施供肝和病肝病切除及肝脏血液流出道重建.移植后每天查血和引流物细菌培养1次,每天查动脉血气分析、血常规、肾功能及肝功能检查2次以上.肝移植患者术后常规应用三代头孢雷素、大扶康及更昔洛韦或并用万古霉素等药5~7 d预防细菌、霉菌及病毒感染.主要观察指标:急性肾功能不全发生率、患者的临床特征、尿量变化、治疗转归情况等.结果:肝移植后发生急性肾功能不全19例,死亡5例,14例患者于术后两三周内肾功能恢复正常.肝移植相关肾功能不全的发生与感染、失血性休克,呼吸衰竭和急性呼吸窘迫综合征有关(P < 0.05).结论:肝移植相关肾功能不全的发生率高为51.35%.死亡率为26.32%,早期诊断和治疗肝移植相关肾功能不全是提高肝移植后急性肾功能不全患者治疗成功率的关键.
揹景:肝移植後,由于手術創傷和免疫抑製劑的應用極易造成急性腎功能不全,其診斷和治療,目前尚無統一診斷標準.目的:分析肝移植後腎功能不全的相關因素和診治經驗.設計、時間及地點:2004-01/2006-12在解放軍第四五八醫院完成.對象:肝移植37例,男35例,女2例,年齡37~67歲,平均(48.5±8.9)歲.根據原髮病分為肝硬化組21例,包括乙型肝炎後肝硬化16例,丙型肝炎後肝硬化4例,酒精性肝硬化1例,均為肝硬化失代償期;肝癌組16例.移植後均經病理檢查確診.方法:按揹馱式改進方法實施供肝和病肝病切除及肝髒血液流齣道重建.移植後每天查血和引流物細菌培養1次,每天查動脈血氣分析、血常規、腎功能及肝功能檢查2次以上.肝移植患者術後常規應用三代頭孢雷素、大扶康及更昔洛韋或併用萬古黴素等藥5~7 d預防細菌、黴菌及病毒感染.主要觀察指標:急性腎功能不全髮生率、患者的臨床特徵、尿量變化、治療轉歸情況等.結果:肝移植後髮生急性腎功能不全19例,死亡5例,14例患者于術後兩三週內腎功能恢複正常.肝移植相關腎功能不全的髮生與感染、失血性休剋,呼吸衰竭和急性呼吸窘迫綜閤徵有關(P < 0.05).結論:肝移植相關腎功能不全的髮生率高為51.35%.死亡率為26.32%,早期診斷和治療肝移植相關腎功能不全是提高肝移植後急性腎功能不全患者治療成功率的關鍵.
배경:간이식후,유우수술창상화면역억제제적응용겁역조성급성신공능불전,기진단화치료,목전상무통일진단표준.목적:분석간이식후신공능불전적상관인소화진치경험.설계、시간급지점:2004-01/2006-12재해방군제사오팔의원완성.대상:간이식37례,남35례,녀2례,년령37~67세,평균(48.5±8.9)세.근거원발병분위간경화조21례,포괄을형간염후간경화16례,병형간염후간경화4례,주정성간경화1례,균위간경화실대상기;간암조16례.이식후균경병리검사학진.방법:안배타식개진방법실시공간화병간병절제급간장혈액류출도중건.이식후매천사혈화인류물세균배양1차,매천사동맥혈기분석、혈상규、신공능급간공능검사2차이상.간이식환자술후상규응용삼대두포뢰소、대부강급경석락위혹병용만고매소등약5~7 d예방세균、매균급병독감염.주요관찰지표:급성신공능불전발생솔、환자적림상특정、뇨량변화、치료전귀정황등.결과:간이식후발생급성신공능불전19례,사망5례,14례환자우술후량삼주내신공능회복정상.간이식상관신공능불전적발생여감염、실혈성휴극,호흡쇠갈화급성호흡군박종합정유관(P < 0.05).결론:간이식상관신공능불전적발생솔고위51.35%.사망솔위26.32%,조기진단화치료간이식상관신공능불전시제고간이식후급성신공능불전환자치료성공솔적관건.
BACKGROUND: Acute renal insufficiency (ARI) usually occurred following liver transplantation due to the surgical trauma and the application of immunosuppressant, which lack of unified diagnostic criteria. OBJECTIVE: To investigate the experience of diagnosis and treatment of ARI following liver transplantation.DESIGN, TIME AND SETTING: The experiment was performed at the 458 Hospital of Chinese PLA from January 2004 to December 2006.PARTICIPANTS: A total of 37 cases received liver transplantation, including 35 males and 2 females, aged 37-67 years, mean aged (48.5±8.9) years. All cases were divided into the liver cancer group (n=16) and liver cirrhosis group (n=21). The liver cirrhosis group included 16 cases with posthepatitic type B cirrhosis, 4 with posthepatitic type C cirrhosis, and 1 with alcoholic cirrhosis. All these cases were in decompensation stage. The final diagnosis was performed by pathological examination. METHODS: The removal of kidney and construction of blood outflow tract was achieved by modified piggy-back liver transplantation. The arterial blood gas analysis, blood routine examination, renal function and liver function were examined more than twice per day. The cephalosporins, Fluconazole and ganciclovir or vancomycin were used for 5-7 days to prevent infections.MAIN OUTCOME MEASURES: The incidence rate of acute ARI, clinical features and outcomes of patients were observed.RESULTS: ARI developed in 19 patients with liver transplantation, 5 patients died, 14 patients recovered in 2-3 weeks. The incidence of ARI following liver transplantation was associated with infection, bleeding shock, respiratory failure and acute respiratory distress syndrome (P < 0.05). CONCLUSION: The incidence of ARI following liver transplantation was 51.35%, with 26.32% mortality rate. The early diagnosis and treatment are the key steps for increasing successful rate of ARI treatment following liver transplantation.